World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Reimagining stem cell cultivation

Reimagining stem cell cultivation

by admin | Jan 17, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Susan Buckles MayoClinic.com (link to article) Mayo Clinic has discovered how to microencapsulate pluripotent stem cells to potentially make them easier and less expensive to process and more effective for fighting disease. This research by Alexander Revzin, Ph.D.,...
Stem Cells or PRP for Equine Tendon and Ligament Injuries?

Stem Cells or PRP for Equine Tendon and Ligament Injuries?

by admin | Jan 15, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Alexandra Beckstett, The Horse Managing Editor, TheHorse.com (link to article) Indications for their use and how veterinarians choose between the two therapies. In recent years, there’s been tremendous interest in using regenerative therapies (or, more accurately,...
First-ever pig-to-human heart transplant offers hope for thousands in need of organs

First-ever pig-to-human heart transplant offers hope for thousands in need of organs

by admin | Jan 14, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Karen Weintraub – January 10, 2022 – APNews.com  (link to article) A Maryland man has lived for three days with a pig heart beating inside his chest. The surgery, at the University of Maryland Medical Center, marks the first time a gene-edited pig has...
Bayer Strikes “Mammoth” CRISPR Deal to Bolster Cell and Gene Therapy

Bayer Strikes “Mammoth” CRISPR Deal to Bolster Cell and Gene Therapy

by admin | Jan 13, 2022 | Uncategorized

By Alex Keown – Jan 10, 2022 – biospace.com (link to article) Bayer and Mammoth Biosciences forged a strategic collaboration potentially valued at more than $1 billion. The partnership grants the Germany-based pharma giant access to Mammoth’s CRISPR...
Pfizer Makes Foray Into CRISPR, Inking .35 Billion Deal With Beam Therapeutics

Pfizer Makes Foray Into CRISPR, Inking $1.35 Billion Deal With Beam Therapeutics

by admin | Jan 12, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By: ALLISON GATLIN – Investors.com – 01/10/2022 (link to article) Pfizer (PFE) is entering the CRISPR space through a $1.35 billion deal with Beam Therapeutics (BEAM), the companies announced Monday. But Beam stock fell on the deal. Beam is using CRISPR...
Page 25 of 114« First«...1020...2324252627...304050...»Last »

Recent Posts

  • Stem cell model replicates human amniotic sac development past two weeks
  • Infant becomes world’s first patient to undergo personalized gene-editing treatment
  • Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
  • Embryonic macrophages found to control blood stem cell numbers in bone marrow
  • Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
  • The stem cell race for Parkinson’s disease: Recent studies show significant promise
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow